Lilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling
BioSpace
A trifecta of newly inked tech partnerships--from Eli Lilly, Bristol Myers Squibb and Incyte--exemplify the increasingly central role that AI is playing in drug development.
pharminent
May 21, 2026 (Last updated: May 21, 2026)
BioSpace
A trifecta of newly inked tech partnerships–from Eli Lilly, Bristol Myers Squibb and Incyte–exemplify the increasingly central role that AI is playing in drug development.
